News

Do you have a clinical research project that will need international collaboration to be successfully completed? 

PLATO-VTE - an INVENT Endorsed Study, recently completed study recruitment. We sat down for a Q&A with PhD Student & Lead Investigator Dr. Noémie Kraaijpoel to talk about the milestone and next steps for the study.

The Network held its fall cycle of the INVENT Kickstarter Awards in September. After receiving several highly competitive applications, three studies have been selected to receive INVENT Kickstarter funding: 

October 1, 2019 - The INVENT Network has formally endorsed the COBRRA Trial: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism - an open-label RCT (randomized controlled trial) comparing bleeding risk with rivaroxaban versus apixaban for acute treatment of VTE (venous thromboembolism)...

Cambridge University Hospitals NHS Foundation Trust are conducting a survey of clinicians that regularly treat and make decisions for patients with venous thromboembolism and would like your help. The survey is looking at how clinicians decide on treatment of patients...

Melbourne, Australia  - At the Annual General Meeting (Council) on July 9th, 2019 at ISTH 2019 Congress in Melbourne, Australia, INVENT Council endorsed four clinical VTE studies / trials. The following studies were endorsed by the network...

Congratulations to Dr. Leslie Skeith (CanVECTOR Network) on winning the 2019 INVENT Dragons' Den Competition in Melbourne, Australia at ISTH 2019 Congress. As the winner of the competition, Dr. Skeith is awarded the $35,000 (CAD) INVENT Inter...

View the program information and list of presenters here.

INVENT Endorsed High Low study (LMWH to Prevent Recurrent Venous Thromboembolism in Pregnancy: A Randomized Controlled Trial of Two Doses) has recruited 767 patients of 1000 patients - as of February 25, 2019. The study began in 2013 and has sites in seven counties par...

INVENT Endorsed RIVASVT-100 Pilot Study (Treatment of Splanchnic Vein Thrombosis With Rivaroxaban: A Pilot, Prospective Cohort Study) has 64 patients of 100 patients - as of January 2019. The study is expected to complete recruitment this spring/summer with 36 patients...